Clinical Study

A Case-Control Study of Involvement of Oxidative DNA Damage and Alteration of Antioxidant Defense System in Patients with Basal Cell Carcinoma: Modulation by Tumor Removal

Table 3

Expressions of oxidative DNA damage, DNA repair enzyme, and antioxidant proteins in skin tissues of control subjects and BCC patients by IRS.

ParametersControls ()Cases ()
EpidermisBCCAdjacent epidermis

8-oxo-dGuo2.30 ± 0.672.88 ± 0.302.27 ± 0.72
hOGG12.56 ± 0.471.77 ± 0.402.53 ± 0.47
CAT1.79 ± 0.631.18 ± 0.742.00 ± 0.48
GCLC2.17 ± 0.571.59 ± 0.562.70 ± 0.45
GPx2.02 ± 0.371.24 ± 0.511.73 ± 0.41
Nrf22.40 ± 0.571.53 ± 0.472.33 ± 0.44
MnSOD1.95 ± 0.531.41 ± 0.652.60 ±  0.46

Results were expressed as mean ± standard deviation (SD).
, , compared to epidermis of control.
, compared to BCC lesion.